MMIT - Managed Markets Insight & Technology

  • Home
  • MMIT - Managed Markets Insight & Technology
Call Directions Website Contact the practice

MMIT - Managed Markets Insight & Technology We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered.

02/11/2026

Behind every confident market access decision is an intelligence engine doing the heavy lifting on the data.

Mission Control from MMIT is built to be exactly that, informing the calls market access teams make every day without the guesswork.

Get the full debrief: https://vist.ly/5r3vz

02/11/2026

Real talk: "call prep" for most reps is four browser tabs open in a parking lot with eight minutes to go.

That's not a rep problem. That's a tools problem.

MMIT's FieldFocus turns scattered HCP data into a call-ready physician targeting plan before the rep even reaches for the door handle.

Territory scored. Guidance ready. Right forms in hand when the conversation pays off.

Every visit, worth it. https://vist.ly/5r3sr

02/11/2026

A simulation shows you how a committee decides. Sometimes you also need to hear why.

Two new P&T Perspectives formats put you in direct conversation with the Norstella Panel of active P&T decision-makers:
🔹 Ad Board and Simulation Hybrid: watch the committee react to your clinical and financial story, then ask the same panel to explain their thinking
🔹 P&T Advisory Board: test and validate your value proposition and messaging in real-time dialogue

Explore both formats and find the right fit for your next decision. https://vist.ly/5q2un

02/11/2026

MMIT is the market access intelligence engine behind your team's decision-making. Your mission control.

Gold-standard coverage data, AI-driven efficiency, and human expertise work together, so you can navigate the unknown with confidence.

Plan your launch with MMIT and learn how we're illuminating the path to patient access: https://vist.ly/5qzef

Q2 2026 brought enrollment shifts across exchange, Medicaid, commercial, and Medicare.Swipe through the carousel for the...
01/11/2026

Q2 2026 brought enrollment shifts across exchange, Medicaid, commercial, and Medicare.

Swipe through the carousel for the market-by-market view.

Track enrollment trends across health plans in MMIT’s Directory of Health Plans: https://vist.ly/5qwxd

31/10/2026

Data alone doesn't move a launch. Acting on it does.

MMIT turns 30+ years of pharma data and AI-driven market access intelligence into the next right move, so teams decide with confidence instead of guesswork.

Plan your launch with MMIT and learn how we're illuminating the path to patient access: https://vist.ly/5quax

31/10/2026

https://vist.ly/5qtq7 | Payer policy changes should not come as a surprise. MMIT Searchlight delivers AI-powered alerts in as little as 24–48 hours, so teams can stay ahead of key formulary and policy updates without manual monitoring.

Learn how Searchlight turns payer noise into clear, actionable insight. Click the link to learn more.

Behind every confident market access decision is an intelligence engine doing the heavy lifting.MMIT is built to be your...
31/10/2026

Behind every confident market access decision is an intelligence engine doing the heavy lifting.

MMIT is built to be your mission control, informing the calls market access teams make every day.

Get the full debrief: https://vist.ly/5qt7u

30/10/2026

MMIT's payer and formulary data help you navigate market access with precision and agentic speed. But that's just one piece of a complex puzzle: R&D, market access, evidence generation, and commercialization all have to come together.

Norstella, MMIT's parent company, does just that. As the AI company for biopharma's highest-stakes decisions, Norstella is trusted by every Top 100 pharma company and industry experts worldwide.

Together with our sister companies — Citeline, Evaluate, Panalgo, Skipta, and the Dedham Group — we're connecting data, solutions and services across the entire drug life cycle.

Follow Norstella to see how the puzzle comes together.

30/10/2026

In some TAs, employer-sponsored benefit decisions play a critical role in access, but many teams struggle for visibility into ASO lives.

In this case study, learn how one pharma company used Landscape iQ to identify priority markets with meaningful self-funded concentration ahead of a new therapy launch. https://vist.ly/5qqr3

Address


Alerts

Be the first to know and let us send you an email when MMIT - Managed Markets Insight & Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMIT - Managed Markets Insight & Technology:

Shortcuts

  • Want your practice to be the top-listed clinic?

Share

Nearby clinics